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AbstActs
background Congenital anomalies (CAs) are a common 
cause of infant death and disability. We linked children 
from a large birth cohort to a routine primary care 
database to detect CA diagnoses from birth to age 5 years. 
There could be evidence of underreporting by CA registries 
as they estimate that only 2% of CA registrations occur 
after age 1 year.
Methods CA cases were identified by linking children 
from a prospective birth cohort to primary care records. 
CAs were classified according to the European Surveillance 
of CA guidelines. We calculated rates of CAs by using 
a bodily system group for children aged 0 to <5 years, 
together with risk ratios (RRs) with 95% CIs for maternal 
risk factors.
Results Routinely collected primary care data increased 
the ascertainment of children with CAs from 432.9 per 
10 000 live births under 1 year to 620.6 per 10 000 live 
births under 5 years. Consanguinity was a risk factor for 
Pakistani mothers (multivariable RR 1.87, 95% CI 1.46 to 
2.83), and maternal age >34 years was a risk factor for 
mothers of other ethnicities (multivariable RR 2.19, 95% CI 
1.36 to 3.54). Education was associated with a lower risk 
(multivariable RR 0.78, 95% CI 0.62 to 0.98).
conclusion 98% of UK CA registrations relate to 
diagnoses made in the first year of life. Our data suggest 
that this leads to incomplete case ascertainment with a 
further 30% identified after age 1 year in our study. Risk 
factors for CAs identified up to age 1 year persist up to 5 
years. National registries should consider using routine 
data linkage to provide more complete case ascertainment 
after infancy.
IntRoductIon
Around 93% of children with a congenital 
anomaly (CA) survive infancy and will require 
varying levels of support from health services.1 
Most registrations reported by CA registers 
in the UK occur very early in life, with less 
than 2% of registrations after 1 year of age.2 
Out of the 36 CA registries in Europe, seven 
reported that more than 2% of cases were 
diagnosed after age 1 year. These later regis-
trations amounted to between 5% and 10% of 
total CA registrations.3 Comparisons between 
registries is made more difficult by inconsist-
encies in the definitions and data variables 
between different registers and by an absence 
of follow-up data.4–8 
This study uses detailed sociodemographic 
and clinical information from the Born in 
Bradford (BiB) prospective birth cohort. The 
incidence of CA in Bradford is high, previ-
ously reported at 306 per 10 000 live births, 
compared with a national average of 227 per 
10 000 live births.2 9 10 The Bradford rate, 
however, is based on case ascertainment up to 
the child’s first birthday, as are 98% of cases 
used to calculate the national rate. We suspect 
this may lead to underascertainment of CA 
and a disparity in both need and demand for 
children’s healthcare. For example, delayed 
diagnoses have been reported in 10% of 
congenital heart defects,11 one of the most 
frequently diagnosed subgroups of CA nation-
ally.2 10 12 Interrogation of diagnoses recorded 
What this study adds
 ► Continuing case attainment to age 
5 years increased the prevalence of congenital 
anomalies (CAs) in our population, from 432.9 
per 10 000 live births at age 1 year to 620.6 at 
age 5 years.
 ► Without accurate case ascertainment, it is likely 
that both general and specialist services for CAs 
will be underresourced.
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Original article
What is already known
 ► Interrogating primary care data for Read medical 
codes is a valid and useful source for ascertaining 
disease prevalence in research studies.
 ► Primary care data linked to prospective birth cohort 
studies allow for detailed, longitudinal analysis.
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Figure 1 Flow diagram of steps in the analysis. BiB, Born in Bradford; PC, primary care.
in the General Practice Research Database (GPRD) also 
revealed the prevalence of heart defects to be nearly 50% 
higher than in European Registers of Congenital Anom-
alies (EUROCAT) projections, with a similar increase 
in prevalence in other system-specific subgroups also 
recorded.13
Higher overall CA prevalence rates have been recorded 
from primary care data sources in comparison with 
national databases, suggesting the utility of primary care 
data to serve as a more complete source of background 
prevalence.12 13 Several other studies report the potential 
of routine primary care databases for CA case ascertain-
ment and diagnoses after age 1 year.5 12–17 These data-
bases generally identify more cases than national registers 
and also have the advantage (over national registers) of 
including information on potential parental and child 
risk factors for CA and clinical information on the child 
across their life course, both of which can be used to 
improve understanding of the causes and consequences 
of CA.5 12–17 However, primary care databases may lack 
information on all diagnoses and will not have system-
atically collected data on potential risk factors using the 
same methods for all children.
objectIve
Our aims were to compare case ascertainment of CA from 
birth to under 5 years between national CA rates and a 
pregnancy/birth cohort linked to primary care data. Our 
a priori hypotheses are that more cases will be ascertained 
from the primary care-linked birth cohort than national 
rates, and the detailed data in the birth cohort will allow 
us to determine whether magnitudes of association for 
risk factors persisted. We compare CA detection between 
the primary care database and the clinically diagnosed 
CA from medical records to determine the accuracy of 
the primary care diagnoses information.
desIgn
setting
We used data from BiB, an ongoing prospective birth 
cohort study, which recruited 12 450 pregnant women 
between 2007 and 2011. The BiB methods are reported 
in detail elsewhere.18
case ascertainment and coding methods
BiB recruits gave their consent to access electronic 
primary care records held on SystmOne,19 the patient 
contact single-source system that currently has complete 
coverage in Bradford and is linked to BiB baseline ques-
tionnaire data. This linkage provides a unique data set 
comprising detailed social, environmental and clinical 
data on the mothers and children in the study. Primary 
care data were extracted for each child when there was 
an exact match for the National Health Service (NHS) 
number, surname, date of birth and gender between Syst-
mOne19 and BiB. Of 13 857 recruits, 97% were matched 
to primary care data, forming the study population. In all, 
there were 74 386 person-years of data, and the average 
time over which data were recorded in the primary care 
record was 5.5 years, with a maximum of 7.6 years. Not 
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all children had reached age 7 years, so we censored our 
follow-up of these cases to under age 5 years. SystmOne19 
assigns any diagnosis a CTV3 Read medical code. We 
mapped Read codes to the International Classification of 
Diseases, 10th Edition (ICD-10) codes to allow anomaly 
classification, with assignment to an anomaly group 
based on the system affected and syndrome (where appli-
cable). We followed the EUROCAT guidelines,20 using 
the British Isles National Organisation of CA Registers 
(BINOCAR) methodology.2 A codebook of both major 
and minor CAs was mapped to Read codes extracted 
from the primary care database using cross mapping.21 
Classifications were reviewed by a clinical geneticist (ES).
sensitivity analyses
We validated the original mapping of CTV3 Read codes to 
ICD-10 by repeating the mapping process with different 
members of the research team. We recorded all cases up 
to the date the child left the primary care practice (ie, 
had died or moved away), the date the practice stopped 
recording primary care appointment data or the date of 
the child’s last appointment at time of data extraction 
(July 2016). A child was classified as having a CA if one 
or more Read codes for CA were recorded in the child’s 
primary care record at any time during which the child was 
registered at the practice. From combining CAs reported 
in the previous BiB data set10 (phase 1 ‘notifications’), 
which were children identified by a standard hospital 
notification system ages 0 to <1 year and confirmed by a 
clinical review, and CA identified in primary care data 
(phase 2 ‘data linkage’) ages 0 to <5 years, we found 296 
CAs reported by both phase 1 and phase 2 methodolo-
gies. We were able to validate whether phase 1 and phase 
2 diagnoses matched, an important step in determining 
whether clinical diagnoses made in hospital matched 
Read code entry into primary care databases (figure 1). 
We reached 83% agreement. We then calculated the 
prevalence of CA overall and for bodily system-spe-
cific subgroups for children diagnosed between ages 
0 and <5 years. We also calculated prevalence up to age 
1 year for comparison with EUROCAT registries. We also 
found 127 CAs (17%), which did not match between 
phase 1 and phase 2 methodologies. On further inspec-
tion, these cases had ICD-10 codes outside of the  27th 
June CA chapter as recommended by EUROCAT. The 
clinicians responsible for the phase 1 study explained 
this was due to some conditions being so rare they could 
not find an appropriate code within the recommended 
CA ICD-10 chapter. Other reasons included the death 
or moving primary care practice more than one time, 
causing potential errors in their diagnoses records.
Risk factors
We reviewed the following maternal risk factors for 
CA: ethnic origin (White British, Pakistani and Other); 
age of mother (<20, 20–34 and >34 years); educa-
tional attainment (less than five General Certificate of 
Secondary Education (GCSE) equivalents; five or more 
GCSE equivalents at grades A–C; two Advanced Level 
equivalents; diploma, degree or higher degrees; other; 
unknown; and foreign unknown); socioeconomic status 
(Index of Multiple Deprivation 2010 (IMD)22); smoking 
(whether mother smoked during pregnancy or not); 
alcohol consumption (drank alcohol during pregnancy 
or 3 months before pregnancy (yes or no)); and consan-
guinity (first cousin, second cousin, other blood relation 
(less than second cousin) or non-consanguineous). We 
categorised results for body mass index (BMI) and oral 
glucose tolerance test in accordance with WHO guide-
lines.23 24
statistical analysis
For risk factors, we estimated univariate risk ratios (RRs) 
and 95% CIs for the occurrence of an anomaly with 
Poisson regression and robust error variance. We calcu-
lated risks for all ethnic groups and separately for White 
British, Pakistani and other groups. The CIs for smoking 
and BMI included one in univariate analyses and so were 
not included in multivariable analyses. We performed 
a test for interaction between consanguinity and IMD 
score. To address issues of multiple testing, all models 
were rerun using 99.9% CIs (data not shown). All anal-
yses were performed in Stata (version 13).
Results
An additional 437 children with a CA were identified 
using the primary care database. Comparison of rates 
with BINOCAR was based on 1408 CAs noted in the total 
of 860 children remaining after the exclusion of minor 
CA. Table 1 compares the prevalence of anomalies in 
Bradford with National data reported by BINOCAR.2 In 
2014, BINOCAR reported a prevalence (based on 2012 
data) for CA, excluding chromosomal disorders, of 184 
per 10 000 live births (table 1).2 Up to age 1 year, we 
report a total CA rate of 376 per 10 000 live births and 
a rate of 571.6 per 10 000 live births, including cases 
ascertained in all children under 5 years. Both these rates 
specifically exclude children with chromosomal or meta-
bolic disorders. This difference in exclusions is due to 
BINOCAR registering children with metabolic disorders 
only if they also have a structural anomaly. BiB includes 
children with metabolic disorders whether or not they 
had a structural anomaly. Despite the large difference in 
BINOCAR rates at age 1 year and BiB rates at age 1 year, 
the phase 1 study10 found a similar 305.74 per 10 000 
live births, helping to explain the influence of the Brad-
ford demographics on the high numbers, before addi-
tional cases are added post age 1 year using primary care 
records. Regression analyses were based on 706 children 
with CA, including metabolic and chromosomal condi-
tions for whom BiB questionnaire data were available. 
The comparison group was the 10 768 cases without CA 
but for whom questionnaire data were available.
Table 2 shows the characteristics of mothers in the 
BiB study who gave birth to children with or without CA, 
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Table 1 Comparison of CA prevalence per 10 000 live births comparing BiB and BINOCAR data
All live births in the BiB cohort
(n=13 857) BINOCAR
Total*
Total 
excluding chromosomal 
and metabolic 
anomalies*
Total
Live births 
only 
(259 714)
Live births 
and 
stillbirths 
(260 927)
Total excluding 
chromosomal 
anomalies
≤1 year 
old
Age 0–<5 
years
≤1 year 
old
Age 0–<5 
years
Any CA 432.9 620.6 376.0 571.6 226.5 168.2 171.5 183.6
Nervous system 93.8 215.1 73.6 192.7 26.4 10.2 10.9 23.6
Heart 91.7 122.7 90.9 116.2 60.2 50.7 51.8 51.4
Respiratory 11.5 16.6 10.1 14.4 9.8 6.3 6.6 8.9
Orofacial clefts 25.3 27.4 25.3 25.9 14.3 12.6 12.9 13.2
Digestive system 39.7 48.4 35.4 37.5 18.1 15.3 15.7 16.2
Abdominal wall 
defects
2.2 2.9 2.2 2.9 9.1 5.3 5.4 7.3
Urinary 49.1 64.2 44.0 49.8 27.8 22.1 22.5 26.7
Genital 37.5 51.2 37.5 44.7 17.9 16.9 17.1 17.4
Limb 44.7 57.7 44.0 53.4 34.9 28.9 29.6 32.2
Other/syndromes 6.5 4.7 4.8 6.06
  Skeletal 
dysplasia
5.8 18.0 5.1 12.3 1.5 1.0 1.0 1.5
  Genetic 
syndromes and 
microdeletions
13.0 17.3 11.5 14.4 4.9 4.0 4.0 4.6
  Sequences 7.9 10.8 7.9 10.1 2.3 1.3 1.4 –
  Chromosomal 25.3 32.5 0.00 0.00 43.0 14.9 16.6 –
BiB, Born in Bradford; BINOCAR, British Isles National Organisation of CA Registers; CA, congenital anomaly.
combining cases from phases 1 and 2. Table 3 shows the 
univariate and multivariable analyses of the risk factors 
included in table 2. The cohort was multiethnic, with 
40% White British, 45% Pakistani and 15% reporting 
different ethnicities we refer to as ‘Other’ (table 2). In 
keeping with rates from phase 1,10 the proportion of 
children with anomalies born to Pakistani mothers was 
higher than those born to mothers in the cohort overall 
(53% for Pakistani children and 47% for White British 
and Other combined). Figure 2 demonstrates the age 
of the child when they received their first CA diagnoses. 
Without the additional cases from primary care data, 
this plot would only show diagnoses up to age 1 year, a 
total of 600 children. Primary care data add a further 260 
cases (30%).
Less than 1% of children of White British origin 
with CA were the offspring of first cousin unions 
compared with 49% of children with CA in the first 
cousin Pakistani subgroup. There was a positive step-
wise association between the CA prevalence and the 
degree of consanguinity in the Pakistani subgroup: 
9.5% of first cousin progeny, 7.7% of second cousin 
progeny, 7.5% of beyond second cousins and 4.8% in 
non-consanguineous progeny. Sixty-six per cent of the 
BiB cohort who had completed questionnaires lived in 
areas defined by the IMD as the most deprived fifth of 
England (table 2). The adjusted rates show an excess risk 
to children born to mothers in the least deprived fifth 
overall, which was also shown in phase 1.10 However, 
the numbers are very small and thus should be treated 
with caution (table 3). Consanguinity was found to be 
a major risk factor for CA in Pakistani mothers in both 
adjusted and unadjusted rates (multivariable RR 1.87, 
95% CI 1.46 to 2.38) and maternal age >34 years for 
mothers of other ethnicities (multivariable RR 2.19, 
95% CI 1.36 to 3.54). Conversely, a higher level of 
education was associated with a low risk of CA (multi-
variable RR 0.78, 95% CI 0.62 to 0.98) (table 3).
dIscussIon
In the most recent BINOCAR report of data for 2012, 
less than 2% of live births were diagnosed after 1 year 
of age.2 Using primary care data on children aged 
0–<5 years revealed an additional 437 children with 
CAs, almost two times of those previously reported in 
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Figure 2 Total number of CA diagnoses per year, and 
additional CA diagnoses per year using phase 1 and phase 2 
data combined.
phase 1.10 Only 70% of diagnoses in the present study 
were made prior to the children’s first birthday. Similar 
results have been reported by others and confirm the 
value of primary care data as a source to investigate 
CA.5 12–17 One review of CA reported in a UK database 
of primary care records (The Health Improvement 
Network) revealed that 72% of cases were diagnosed 
up to age 1 year, and after including diagnoses made 
up to age 5 years, rates increased from 198 per 10 000 to 
277 per 10 000.12 The overall prevalence of heart 
defects was reported as lower for infants diagnosed up 
to age 1 year than infants diagnosed up to age 6 years 
in a further primary care database study.14 Late detec-
tion of heart CA could be attributable to some cases 
being missed at antenatal screening due to detection 
being difficult.25 Two studies using the GPRD found 
an increase in CA diagnoses when post-age 1 year CA 
diagnoses were included.14 17 Excluding chromosomal 
and metabolic conditions and considering diagnoses 
for age 0–<5 years, we found the profile of disorders in 
terms of bodily system categories to be consistent with 
those reported previously.2 10 12 26 The only exception 
is nervous system disorders, seen as the most common 
group in our study and in CA research specific to the 
UK.2 10 Considering the percentage increase by bodily 
system group, skeletal dysplasias increased considerably 
from age 1 year to age 5 years (210%), primarily due to 
diagnoses of short stature, followed by nervous system 
(77%), due to an inflation of hearing loss in Bradford, 
and respiratory (44%) disorders that are known to be 
high in Bradford27 (table 1). Some of the conditions in 
these subgroups are not expected to be detected in the 
prenatal period,8 but our data suggest that they may 
be taking longer to diagnose than previously thought, 
which has significant clinical implications. Delayed 
diagnoses are seen to create increased complications 
with care coordination and create a reliance on emer-
gency care.28–31 We also assessed the effect of improved 
ascertainment on the point estimates and statistical 
significance of the risk factors for CA. We found no 
substantial change in these risk factors, even with a 
slightly different CA profile. Changes to statistical 
significance of risk factors would have had implica-
tions for comparative analyses between registries with 
different ascertainment methods.
Our findings, combined with other primary care data-
base studies for CA ascertainment, therefore suggest 
that there are more than 2% of CA diagnoses being 
made after age 1 year, and registries may need to be 
more specific about their data collection methods for 
later diagnoses. In England, the recently established 
National Congenital Anomaly and Rare Disease Regis-
tration Service (NCARDRS)32 specify that they collect 
data, including risk factors, via notifications after age 
1 year. The service is new, and the longer-term picture 
in terms of comprehensive ascertainment is not yet 
known. Our study demonstrates that ascertainment is 
strengthened with the use of routine NHS data sources. 
Consequently, the increased prevalence of children 
living with CAs in the community may require addi-
tional specialist resources for paediatric, obstetric and 
genetic care for this, as-yet, underascertained cohort. 
The results could also have implications for transition 
to adult services.
There are limitations to our study. The time of diag-
noses based on Read code entry into primary care 
systems has been reported as later, on average, than 
dates of actual diagnosis by general practitioners.17 
The cross mapping of Read to ICD-10 is vulnerable to 
discrepancies due to multiple Read codes matching 
one ICD-10 code. We accounted for this by performing 
a clinical review, assigning the most appropriate Read 
code to ICD-10 match. CA cases that are stillborn or 
diagnosed antenatally, resulting in termination, are 
not well recorded in women’s primary care records, 
thus underestimating CA cases. NCARDRS highlights 
that 71% of CA are detected antenatally, and 42% of 
CA diagnosed antenatally resulted in termination.32 
Another CA study found fetuses diagnosed with a 
major CA had a high likelihood of termination of 
pregnancy, at 50% for consanguineous unions and 
at 60.9% for non-consanguineous pregnancies.33 BiB 
does not report terminations of pregnancy or miscar-
riages because recruitment is at 26–28 weeks gestation. 
This current, unpublished work on the BiB cohort has 
revealed a high level of concordance between self-re-
port of consanguineous marriage and genetic related-
ness. There is also a suggestion that the level of genetic 
relatedness exceeds that expected from self-report, and 
this may be a function of traditional male socio-occupa-
tional groupings. These aspects are being investigated 
in the BiB cohort as part of an ongoing programme of 
research.34
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conclusIon
We have combined personal and clinical information 
from a large cohort study with routine primary care data 
to produce a more comprehensive assessment of the 
burden of CA in live births. We have demonstrated that 
more complete case ascertainment of CA can be achieved 
by linking to primary care data, and by using these, data 
we are able to detect later diagnoses up to the age of 
5 years. Our study also reaffirms consanguinity as a major 
risk factor for CA in the Bradford Pakistani community.
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